chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a medical assistant and a 23 year old medical secretary concerning herself who on 18-SEP-2006 was vaccinated intramuscularly with the first 0.5 mL dose of Gardasil (lot #"069F").  On 28-SEP-2006, the patient was vaccinated intramuscularly with the second 0.5 mL dose of Gardasil (lot #653937/0637F).  On 22-FEB-2007 the patient was vaccinated with the third dose of Gardasil (lot #653937/0637F).  The patient reported that she "experienced a 20 minute period of parasthesia (numbness and tingling) in the arm after the first and second dose of the vaccine were administered."  Patient stated she "did not have the same experience after receiving the third dose."  The patient sought unspecified.  The patient recovered.  There was no product quality complaint.  Additional information has been requested.
First 3 days, arm was sore, fever, nausea and day 3, vomiting. Every single day since, off and on throughout the day: fever (99-101.9), nausea, headaches in the front part of the head, clammy feeling and lethargic. Starting 5/1, now been dizzy every day. We are on day 22 since the vaccine and this is still happening.
One day after second vaccination, dizzy spells, anxiety leading to ER visit due to chest pain.  Extreme upper and lower GI inflammation resulting in a forced liquid diet for two and a half weeks, as nothing else "fit".  Extremely strong case of GERD requiring medicine to help control (took two weeks to become effective) that is only just now starting to clear up.  Persistent muskuloskeletal pain in chest.  Light headedness and dizzyness continue to occur sporadically during times of resting.   Chronic backpain likely unrelated, which began about a month and a half ago.
Excessive irritability-unable to console for 24 hrs, beginning 36 hrs p/inject; erythema & 3cm induration devel @ site of DTP;
Chills, fever-diminished   sweats-resolved 4/5/2021  migrating erythema, tenderness under erythema, anorexia, bladder irritation-persistent
Had Pedvax / Hib, Prevnar on 12/17, developed rash on both thighs on 12/18.
15min after receiving vaccine, client started complaining of itching and flushing. The itching was located on pt's back. 25mg of Benadryl was given at this time. Pt denies wheezing or difficulty breathing. About 8 min after original complaint client stated that back was less itchy, still complaining of itchiness on face. No rash was noted by observation RN. Observation RN determined it was safe for client to leave at the end of observation time.
Believes that she had a seizure on the 28th of October along with body aches, fatigue and headache. It came to the attention of a case worker  that she was "spacing out" on a  call 11/9/2021, Client's friend found her mentally unresponsive (client states she cannot remember a thing) she was then transported to hospital via ambulance.  Still reports having body aches (hands and back of her neck), fatigued
This patient received the Janssen COVID-19 Vaccine on 4/10/2021. She was subsequently admitted for ischemic stroke of unknown etiology on 4/16/2021. She was found in the bathroom down on the floor, confused, with right-sided weakness, and aphasia. Patient was treated with TPA.
Information has been received from a physician concerning about 5 patients who on unspecified dates, were vaccinated with GARDASIL vaccine (yeast) and meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA). Subsequently, the patients experienced syncope and saw the physician. The outcome of the event was not reported. No further information is available.
COVID-19 TEST POSITIVE; This spontaneous report received from social media (Johnson and Johnson) via a parent concerned a male of unspecified age, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient previously received covid-19 vaccine ad26. cov2. s (Dose number in series 1) (suspension for injection, route of admin, batch number and expiry were not reported) dose was not reported, administered 1 in total for covid-19 prophylaxis.  Patient was not having any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin, batch number and expiry were not reported) dose, start therapy date were not reported administered 1 in total for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced covid-19 test positive following vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series 2). Laboratory data (dates unspecified) included: COVID-19 virus test Positive. Reported "Best Covid vaccine! My son and I Got our 1st and 2nd J&J vaccine and absolutely no issues! My son later got Covid and not even one symptoms appeared except a + test!" The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid-19 test positive was not reported. This report was non-serious.
He got the first vaccine dose before Christmas and was checked for antibodies which came back negative; This is a spontaneous report from a contactable physician (patient himself) via a medical information team. A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unspecified date in Dec2020 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Caller reports that he thought he would test positive for antibodies after being vaccinated, calling to ask for more information about this as it was not an expected outcome. Question: Caller was a physician, who asks if he should expect to test positive for antibodies after receipt of the first vaccine dose or not. Caller reports that he got the first vaccine dose before Christmas and was checked for antibodies which came back negative on an unspecified date. Caller asks if this was normal and was it because he checked it too soon and asks for any information on antibody testing following vaccination. Used a qualitative total antibody test. Realized after calls end. The outcome of the event was unknown.  Information about Batch/Lot number has been requested.
pt recv vax & begin to have sz w/motor sx & was hosp from 29JUN to 2JUL96;pt cont having sz p/hosp;MD stated pt epilepsy & mild develop delay is from pertussis vax encephalomyelitis;blinking;febrile illness & twitching;
Day of vaccination: High fever ranging from 102 to 104 F reducing to a light fever around 99 F by the evening. Persistent head pain, feelings of fatigue, and nausea.  Day following vaccination: Reduced fever around 99 F and improvements in other side effects all largely going away by the evening of this second day apart from general feelings of fatigue.
Severe persistent headaches that lasted over a week. These were some of the worst headaches I have ever experienced in  my life, and I'm still getting mild headaches even today. I was quarantining before the vaccine, so I am positive it is a side effect. I am not prone to getting headaches. I also felt weak and dizzy at times during the headaches, which lasted all day and impacted my ability to sleep well.
Treated in ED the same day as vaccination for left facial tingling and numbness. Diagnosis from ED of Left 5th nerve Transient Palsy. Resolved in 72 hours.
Parasthesia to left arm, piched nerve pain. BP 165/66; HR 66; RR 18. Provider notified. Hx or Dm, HTN. Denies chest pain, no respiratory distressed.  Advised to f/u with PCP, released from vaccination site in stable condition
Patient reports that the symptoms started within 30 minutes of receiving the vaccine on 10/11/2017.  She reports that the vaccine was given in a good location. She is an RN. She reports swelling (2+ pitting edema) in the left arm and that it became numb down to the middle and ring fingers of that arm. She feels the numbness was because of the swelling. She reports that she developed a heavy tongue, along with a headache and vomiting. She also developed 2+ pitting edema in her legs. She reports that at the time of the vaccination she was 28 weeks and 5 days pregnant. She reports that she had a 10 pound plus weight gain associated with the event. She notes that she also has a splotchy rash on her chest, arms and legs. She reports that she took Benadryl and this helped with the symptoms. As of today, 10/18/2017 she reports that she has lost 6 of the pounds that she gained. She reports that swelling has resolved, though her arm is still slightly sore. She still gets the rash intermittently. She reports that she has told her Midwife about this event and she states that they did do an ultrasound and the baby is fine.
Report A0370606A describes joint stiffness in a 35 year old female who received Lyme disease vaccine recombinant OspA. This report was received from the vaccinee and has not been verified by a physician or other healthcare professional. The vaccinee reports a possible allergy to codeine. Concomitant medication included prenatal vitamins NOS prior to her daughter's birth. The maternal grandmother had osteoarthritis with pain but no deformities. The vaccinee stated that she "was an active person who runs a lot and has for all of her life." In approximately March 2000 and May 2000, the vaccinee received her first and second injections of LYMErix, respectively. At an unknown time, within the past three years, she began experiencing "overall stiffness in joints including stiffness in knees, shoulders, elbows, neck." She also reported knee pain. These symptoms reportedly did not occur every day. She stated that she did not know if her symptoms could be just old age or if they could be a result of the vaccination. She stated that she did not feel it was necessary to contact her physician concerning her symptoms. The LYMErix series was discontinued. The info received on 06/04/2002 reported the events to be ongoing. Additional info has been requested.
This spontaneous report was received from a healthcare workers referring to a 30 to 40 patients of unknown age and gender. Since an unknown date in September 2015 (the vaccinations occurred within the past 2 weeks) the patients were vaccinated with improperly stored doses of (Merck) PROQUAD (dose and frequency were not reported, lot #K022448 with expiration date: 13-MAY-2016, lot #K025766 with expiration date: 08-JUN-2016). No adverse effect reported. This is one of the several reports received from the same reporter. Additional information is not expected. Reporters did not wish to be contacted.
Uncontrollable shaking for roughly 1-hour and 20-minutes. Convulsive as though extreme hypothermic, patient could not control it.  Shaking was so severe that my wife woke up in bed (heavy sleeping) and was so concerned that she was going to call 911, instead she called ER first and they said they couldn't provide any advice. I said I felt cold, even though I had a fever that was extremely high (no thermometer to measure) my wife then put the 30lb weighted blanket on me and after about 15-minutes the shaking started to decrease before finally subsiding completely. I then had a drink of water at room temperature which lowered my internal core body temperature and slight shaking started again until I warmed back up and stopped. Our house was 73 degrees F which normally I would sleep in my underwear, instead I was fully dressed, under all our blankets plus the 30lb weighted blanket and I still felt cold.  That night I had sweated more than ever, my pillow was literally a swamp and stayed damp until the next night although pillow cases were removed. Half of the king size bed was soaking wet and yet I still felt cold.  I sweated through the sheets again for 2 more nights before my body finally started regulating its temperature again and have since been okay. Felt very lethargic for 5-days.
Child (4 mo) admin. expired dose of ROTATEQ on 12-14-10 per order from Dr. parent to be called for redose of child 4 wks from previous dose on or after 1-14-11.
has stomach cramps becoming more severe; His first two shots were Moderna; His first two shots were Moderna; booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 24 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03Jan2022 09:30 (Lot number: FL3197) at the age of 24 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Moderna (1st dose date 28May2021 Lot 047C21A, expiration is unknown. Injected in left arm), administration date: 28May2021, when the patient was 24 years old, for Covid-19 immunization; Moderna (2nd dose date 25Jun2021, Lot 033C21A, expiration is unknown.Injected in left arm.), administration date: 25Jun2021, when the patient was 24 years old, for Covid-19 immunization. The following information was reported: OFF LABEL USE (non-serious), INTERCHANGE OF VACCINE PRODUCTS (non-serious) all with onset 03Jan2022 09:30, outcome "unknown" and all described as "His first two shots were Moderna"; IMMUNISATION (non-serious) with onset 03Jan2022 09:30, outcome "unknown", described as "booster"; ABDOMINAL PAIN UPPER (non-serious) with onset 04Jan2022 10:00, outcome "not recovered", described as "has stomach cramps becoming more severe".
Tightness in chest, chills, sore throat, fatigue extreme, headache, bodyaches and joints, blurry eyes, nausea, no appetite.
Developed numbness in right arm and right leg.  She presented to the Emergency Room for evaluation.  Evaluation with blood tests and CT scans were done/ there was no evidence of a stroke.  She continues to have the numbness although it is somewhat improved. there is no muscular weakness.
HER ARM IS PAINFUL AT THE SITE OF INJECTION AND SHE HAS A FEVER. ALSO HER ARMPIT ON THE VACCINATED ARM HURTS AND IS SWOLLEN
Information has been received from a 75 year old male with no drug reactions or allergies and a history of stroke who in July 2008, "3 years ago", was vaccinated with a dose of ZOSTAVAX (Oka/Merck) (lot #, dose and route not reported) along with a dose of AFLURIA (manufacturer unknown) (lot #, dose and route not reported) at the same time. Concomitant therapy included blood thinner (unspecified). The patient stated that he then experienced vertigo in which he became hospitalized. No treatment was given for the event. No lab diagnostics studies were performed. He said once in a while he still experienced vertigo as a result. He was hospitalized for one week. At the time of the report, the patient was recovering. No further information is available.
Fever up to 103 degrees x 2 days, very fussy; emesis x 1 1st day; symptoms started 30 minutes after IZ administration.
Shortness of breath upon exertion; Chest pain and tightness; Chest pain and tightness; Migraine with visual aura; This spontaneous case was received on 11-Oct-2020 from other non-health professional via Health Authority (reference number: SEQW20-03357) and concerned a 27-year-old, female patient.  The patient's past medical history included migraines. The patient's concomitant medications included buspirone, bupropion, Albuterol (salbutamol), and rizatriptan.  On 10-Oct-2020, the patient was vaccinated with Afluria Quadrivalent (influenza vaccine, dose: 0.5 ml, route of administration: intramuscular; anatomical location: deltoid) for influenza prophylaxis. The batch number reported was P100255594. This was the first influenza vaccine the patient received.  On the same day, two hours after receiving Afluria Quadrivalent, the patient experienced chest pain and tightness and shortness of breath upon exertion. In the evening the patient experienced migraine with visual aura. Physician advised the patient to use Albuterol inhaler and take Tylenol (paracetamol).  On an unknown date in Oct-2020, the patient recovered from the event of 'migraine with aura'.  At the time of initial reporting on 11-Oct-2020, the patient had not recovered from the events 'shortness of breath', 'chest pain' and 'chest tightness', as it was reported that the patient continued to experience symptoms.  The reporter did not provide a causality assessment.  The reporter assessed the events as non-serious.  Company comment: A 27-year-old, female patient, was administered Afluria Quadrivalent vaccine. On the same day, two hours after receiving vaccine, the patient experienced chest pain, chest discomfort and dyspnoea exertional. In the evening the patient experienced migraine with visual aura. The patient's past medical history included migraines. The patient's concomitant medications included buspirone, bupropion, Albuterol (salbutamol), and rizatriptan. Causality was highly confounded by concomitant medications. However, causal role of the suspect vaccine cannot be excluded due to plausible chronology and is assessed as unlikely related for chest pain, chest discomfort and dyspnoea exertional. (defaults to "related" in the safety database for reporting purposes) Causality is assessed as not related for migraine with visual aura.; Sender's Comments: A 27-year-old, female patient, was administered Afluria Quadrivalent vaccine. On the same day, two hours after receiving vaccine, the patient experienced chest pain, chest discomfort and dyspnoea exertional. In the evening the patient experienced migraine with visual aura. The patient's past medical history included migraines. The patient's concomitant medications included buspirone, bupropion, Albuterol (salbutamol), and rizatriptan. Causality was highly confounded by concomitant medications. However, causal role of the suspect vaccine cannot be excluded due to plausible chronology and is assessed as unlikely related for chest pain, chest discomfort and dyspnoea exertional. (defaults to "related" in the safety database for reporting purposes) Causality is assessed as not related for migraine with visual aura.
Highly suspicious of MIS-A Initial Moderna dose received in early August,  became ill three days later and tested positive for COVID, hospitalized for four days, required oxygen made full recovery, received second dose of Moderna around 9/16 (exact date unknown) and ten days later became sick with fever, chills, body aches, nausea/vomiting, diarrhea, abdominal pain, presented to ER 9/30, received monoclonal antibody 10/1, returned to ER 10/2 with worsening of above symptoms, found to be hypotensive to 80s systolic, new AKI Cr 3.8. Remained with intermittent fevers as high as 39 through 10/4. Received IV dexamethasone then IVIG 10/4 and 10/5, anakinra started 10/6. TTE with borderline EF at 50% on 10/3. New O2 requirement 10/4 with associated dyspnea at rest and increased interstitial infiltrates on CXR c/w pulmonary edema. Improved with diuresis, satting 95% on room air on 10/7. Afebrile since 10/5 with resolution of n/v/abdominal pain and improving malaise/fatigue/body aches.
About 10 days or so following the second shot, I started to experience skipped heart beats, to a much greater degree and duration than ever in the past.  This continued at that degree for a period of about 2.5 months and now is more sporadic.
aches and pain; skin is sagging on her arm; Soreness at injection site; Redness at injection site; Swelling at injection site; Swelling under her arm/ swollen lymph node; Rash at injection site; Warmness at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warmness at the site of injection), PAIN (aches and pain), SKIN LAXITY (skin is sagging on her arm), VACCINATION SITE PAIN (Soreness at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Warmness at the site of injection), VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE SWELLING (Swelling at injection site), VACCINATION SITE LYMPHADENOPATHY (Swelling under her arm/ swollen lymph node) and VACCINATION SITE RASH (Rash at injection site). On an unknown date, the patient experienced PAIN (aches and pain). an unknown date, the patient experienced SKIN LAXITY (skin is sagging on her arm). The patient was treated with IBUPROFEN for Adverse event, at a dose of 600 and 400mg. At the time of the report, VACCINATION SITE WARMTH (Warmness at the site of injection), VACCINATION SITE PAIN (Soreness at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE RASH (Rash at injection site) was resolving and PAIN (aches and pain), SKIN LAXITY (skin is sagging on her arm) and VACCINATION SITE LYMPHADENOPATHY (Swelling under her arm/ swollen lymph node) outcome was unknown.            Concomitant medications were not reported.  Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow up received 03-Jun-21: Significant information received included adverse events (pain and skin laxity), second dose details.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
A pharmacist reported that an 11 year old female received Pnu-Imune 23 and PROHIBIT vaccines on 8/24/00 and subsequently, developed a fever and an injection site reaction characterized by redness and tenderness. She recovered. This is 1 of 2 pts from this facility who experienced this event following receipt of Pnu-Imune 23 (lot 463729).
1 hour after receiving injection, pt became dizzy, vomited, nauseated, rash on body itching.
severe IBS symptoms; This spontaneous case was reported by a consumer and describes the occurrence of IRRITABLE BOWEL SYNDROME (severe IBS symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced IRRITABLE BOWEL SYNDROME (severe IBS symptoms). At the time of the report, IRRITABLE BOWEL SYNDROME (severe IBS symptoms) outcome was unknown.            No concomitant product was reported.  No treatment information was reported.  Case was received via email with limited information.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-081083, MOD-2021-081083 (Patient Link).
Swollen arm at site of injection and about 4.5" around. Warm and slightly itchy. Yesterday I was tired and slept alot but I felt OK by 3 pm. Then around 11 am today my arm started to swell.